SVA

Sinovac Biotech (SVA)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SVA
DataOraFonteTitoloSimboloCompagnia
29/04/202423:53Business WireSINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-FNASDAQ:SVASinovac Biotech Ltd
21/02/202412:09Edgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]NASDAQ:SVASinovac Biotech Ltd
21/02/202412:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SVASinovac Biotech Ltd
21/02/202408:56Business WireSinovac Amends Shareholder Rights PlanNASDAQ:SVASinovac Biotech Ltd
02/02/202417:19Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:SVASinovac Biotech Ltd
19/01/202412:58Business Wireシノバック取締役会、一方的な部分公開買い付けを全会一致で退けるNASDAQ:SVASinovac Biotech Ltd
18/01/202420:54Business WireSinovac董事會一致反對Alternative Liquidity主動提出的部分公開收購方案NASDAQ:SVASinovac Biotech Ltd
18/01/202420:47Business WireLe conseil d'administration de Sinovac rejette à l'unanimité une offre partielle non sollicitéeNASDAQ:SVASinovac Biotech Ltd
18/01/202419:33Business WireDas Board of Directors von Sinovac lehnt einstimmig ein unaufgefordert abgegebenes Teilkaufangebot abNASDAQ:SVASinovac Biotech Ltd
18/01/202413:13Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:SVASinovac Biotech Ltd
18/01/202413:00Business WireSinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender OfferNASDAQ:SVASinovac Biotech Ltd
08/01/202422:46Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:SVASinovac Biotech Ltd
04/12/202312:01Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SVASinovac Biotech Ltd
12/09/202312:10Business Wireシノバック、新型コロナウイルスに対するSA55抗体注射剤の臨床試験について進展を報告NASDAQ:SVASinovac Biotech Ltd
11/09/202316:36Business WireSINOVAC rend compte des progrès réalisés dans le cadre de son essai clinique concernant l’injection anti-COVID-19 à base d’anticorps SA55NASDAQ:SVASinovac Biotech Ltd
11/09/202316:36Business WireSINOVAC informiert über die Fortschritte bei der klinischen Studie für den Anti-COVID-19-Antikörper SA55 InjectionNASDAQ:SVASinovac Biotech Ltd
11/09/202311:55Business WireSINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 InjectionNASDAQ:SVASinovac Biotech Ltd
06/09/202313:35Business Wireシノバック取締役会、同意なき株式の部分公開買付を全会一致で拒否NASDAQ:SVASinovac Biotech Ltd
05/09/202318:16Business WireSinovac-Vorstand lehnt ein unangefordertes Teilübernahmeangebot einstimmig abNASDAQ:SVASinovac Biotech Ltd
05/09/202317:36Business WireLe conseil d’administration de Sinovac rejette à l’unanimité une offre publique d’achat partielle non sollicitéeNASDAQ:SVASinovac Biotech Ltd
29/08/202319:08Business Wireシノバック、部分的な株式公開買付を一方的に受けたことを確認NASDAQ:SVASinovac Biotech Ltd
29/08/202315:04Business WireSinovac bestätigt den Erhalt eines unangeforderten TeilübernahmeangebotsNASDAQ:SVASinovac Biotech Ltd
29/08/202312:05Business WireSinovac confirme la réception d'une offre publique d’achat partielle non sollicitéeNASDAQ:SVASinovac Biotech Ltd
29/08/202309:07Business WireSinovac Confirms Receipt of an Unsolicited Partial Tender OfferNASDAQ:SVASinovac Biotech Ltd
28/08/202321:40Business Wireシノバック、子会社の法定代理人変更を発表NASDAQ:SVASinovac Biotech Ltd
28/08/202319:19Business WireSinovac meldet Wechsel des rechtlichen Vertreters von Sinovac BeijingNASDAQ:SVASinovac Biotech Ltd
28/08/202317:57Business WireSinovac annonce un changement au niveau du représentant légal de Sinovac PékinNASDAQ:SVASinovac Biotech Ltd
28/08/202313:44Business WireSinovac Announces Change of Legal Representative of Sinovac BeijingNASDAQ:SVASinovac Biotech Ltd
15/08/202312:00Business WireSINOVAC Reports Unaudited First Half of 2023 Financial ResultsNASDAQ:SVASinovac Biotech Ltd
25/05/202313:14Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SVASinovac Biotech Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SVA
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network